|20.18||-0.51 / -2.46%|
Data as of 4:00pm ET
|19.99||-0.1898 / -0.94%|
The 4 analysts offering 12-month price forecasts for Epizyme Inc have a median target of 34.50, with a high estimate of 40.00 and a low estimate of 25.00. The median estimate represents a +70.96% increase from the last price of 20.18.
The current consensus among 5 polled investment analysts is to Buy stock in Epizyme Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.